Listed

Bionano Genomics, Inc.

BNGONasdaqCIK 1411690TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$8.2m, Q2 FY2026
Operating income−$7.2m, Q2 FY2026
Net income−$7.4m, Q2 FY2026
Bionano Genomics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m9.3Revenue, Q3 FY2023, three months to 2023-09-30$9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure10.7Revenue, Q4 FY2023, three months to 2023-12-31$10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure8.8Revenue, Q1 FY2024, three months to 2024-03-31$8.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure7.8Revenue, Q2 FY2024, three months to 2024-06-30$7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure6.1Revenue, Q3 FY2024, three months to 2024-09-30$6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure8.2Revenue, Q4 FY2024, three months to 2024-12-31$8.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure6.5Revenue, Q1 FY2025, three months to 2025-03-31$6.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure6.7Revenue, Q2 FY2025, three months to 2025-06-30$6.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure7.4Revenue, Q3 FY2025, three months to 2025-09-30$7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure8.0Revenue, Q4 FY2025, three months to 2025-12-31$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure6.7Revenue, Q1 FY2026, three months to 2026-03-31$6.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure8.2Revenue, Q2 FY2026, three months to 2026-06-30$8.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Cost of revenue$m6.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$6.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure8.3Cost of revenue, Q4 FY2023, three months to 2023-12-31$8.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure5.9Cost of revenue, Q1 FY2024, three months to 2024-03-31$5.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure5.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$5.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure14.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$14.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure4.7Cost of revenue, Q4 FY2024, three months to 2024-12-31$4.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure3.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$3.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure3.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$3.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure4.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure4.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure3.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure3.9Cost of revenue, Q2 FY2026, three months to 2026-06-30$3.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Research and development$m13.8Research and development, Q3 FY2023, three months to 2023-09-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure11.7Research and development, Q4 FY2023, three months to 2023-12-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure9.8Research and development, Q1 FY2024, three months to 2024-03-31$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure6.8Research and development, Q2 FY2024, three months to 2024-06-30$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure4.7Research and development, Q3 FY2024, three months to 2024-09-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure3.5Research and development, Q4 FY2024, three months to 2024-12-31$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure2.4Research and development, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure2.9Research and development, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure2.8Research and development, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure3.2Research and development, Q4 FY2025, three months to 2025-12-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure3.1Research and development, Q1 FY2026, three months to 2026-03-31$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure3.0Research and development, Q2 FY2026, three months to 2026-06-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Selling, general and administrative$m24.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$24.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure14.9Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$14.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure19.1Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$19.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure11.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$11.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure9.5Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$9.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure11.7Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$11.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure9.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$9.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure8.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$8.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure9.1Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$9.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure8.7Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$8.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure8.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$8.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure8.5Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$8.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Operating income$m(113)Operating income, Q3 FY2023, three months to 2023-09-30−$113.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure(25.0)Operating income, Q4 FY2023, three months to 2023-12-31−$25.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure(31.1)Operating income, Q1 FY2024, three months to 2024-03-31−$31.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure(17.0)Operating income, Q2 FY2024, three months to 2024-06-30−$17.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure(43.9)Operating income, Q3 FY2024, three months to 2024-09-30−$43.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure(11.9)Operating income, Q4 FY2024, three months to 2024-12-31−$11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(8.5)Operating income, Q1 FY2025, three months to 2025-03-31−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(7.8)Operating income, Q2 FY2025, three months to 2025-06-30−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure(8.5)Operating income, Q3 FY2025, three months to 2025-09-30−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure(8.5)Operating income, Q4 FY2025, three months to 2025-12-31−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(7.9)Operating income, Q1 FY2026, three months to 2026-03-31−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(7.2)Operating income, Q2 FY2026, three months to 2026-06-30−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$71.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-08, accession 0001411690-23-000082.Report this figure4.9Interest expense, Q4 FY2023, three months to 2023-12-31$4.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-05, accession 0001411690-24-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2024, three months to 2024-03-31$122.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0001411690-24-000021.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$39.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure(0.0)Income tax, Q4 FY2023, three months to 2023-12-31−$36.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2024, three months to 2024-03-31−$18.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$26.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$24.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$14.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$35.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Net income$m(113)Net income, Q3 FY2023, three months to 2023-09-30−$112.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure(43.9)Net income, Q4 FY2023, three months to 2023-12-31−$43.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure(31.4)Net income, Q1 FY2024, three months to 2024-03-31−$31.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure(16.2)Net income, Q2 FY2024, three months to 2024-06-30−$16.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure(44.2)Net income, Q3 FY2024, three months to 2024-09-30−$44.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure(20.1)Net income, Q4 FY2024, three months to 2024-12-31−$20.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(3.1)Net income, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure(6.9)Net income, Q2 FY2025, three months to 2025-06-30−$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure(8.5)Net income, Q3 FY2025, three months to 2025-09-30−$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure(7.9)Net income, Q4 FY2025, three months to 2025-12-31−$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(8.3)Net income, Q1 FY2026, three months to 2026-03-31−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure(7.4)Net income, Q2 FY2026, three months to 2026-06-30−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Diluted EPS$ per share(3.22)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$3.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figurenot reported(35.75)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$35.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure(14.41)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$14.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure(30.92)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$30.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figurenot reported(1.15)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(1.99)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure(1.59)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figurenot reported(0.76)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(0.64)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Basic EPS$ per share(3.22)Basic EPS, Q3 FY2023, three months to 2023-09-30−$3.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figurenot reported(35.75)Basic EPS, Q1 FY2024, three months to 2024-03-31−$35.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure(14.41)Basic EPS, Q2 FY2024, three months to 2024-06-30−$14.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure(30.92)Basic EPS, Q3 FY2024, three months to 2024-09-30−$30.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figurenot reported(1.15)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(1.99)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure(1.59)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figurenot reported(0.76)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(0.64)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure

Balance sheet

Cash and equivalents$3.7m, Q2 FY2026
Shareholders' equity$31.6m, Q2 FY2026
Bionano Genomics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m34.6Cash and equivalents, Q3 FY2023, at 2023-09-30$34.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure17.9Cash and equivalents, FY2023, at 2023-12-31$17.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001411690-25-000037.Report this figure15.8Cash and equivalents, Q1 FY2024, at 2024-03-31$15.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure10.4Cash and equivalents, Q2 FY2024, at 2024-06-30$10.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure8.8Cash and equivalents, Q3 FY2024, at 2024-09-30$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure9.2Cash and equivalents, FY2024, at 2024-12-31$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001411690-26-000007.Report this figure3.6Cash and equivalents, Q1 FY2025, at 2025-03-31$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure3.6Cash and equivalents, Q2 FY2025, at 2025-06-30$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure3.1Cash and equivalents, Q3 FY2025, at 2025-09-30$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure3.0Cash and equivalents, FY2025, at 2025-12-31$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure3.4Cash and equivalents, Q1 FY2026, at 2026-03-31$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure3.7Cash and equivalents, Q2 FY2026, at 2026-06-30$3.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Current assets$m105Current assets, Q3 FY2023, at 2023-09-30$104.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001411690-23-000082.Report this figure140Current assets, FY2023, at 2023-12-31$140.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001411690-25-000037.Report this figure85.6Current assets, Q1 FY2024, at 2024-03-31$85.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001411690-24-000021.Report this figure60.6Current assets, Q2 FY2024, at 2024-06-30$60.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001411690-24-000049.Report this figure47.0Current assets, Q3 FY2024, at 2024-09-30$47.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure39.5Current assets, FY2024, at 2024-12-31$39.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001411690-26-000007.Report this figure44.9Current assets, Q1 FY2025, at 2025-03-31$44.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure42.7Current assets, Q2 FY2025, at 2025-06-30$42.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure48.8Current assets, Q3 FY2025, at 2025-09-30$48.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure45.4Current assets, FY2025, at 2025-12-31$45.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure39.0Current assets, Q1 FY2026, at 2026-03-31$39.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure24.9Current assets, Q2 FY2026, at 2026-06-30$24.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Total assets$m182Total assets, Q3 FY2023, at 2023-09-30$181.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001411690-23-000082.Report this figure214Total assets, FY2023, at 2023-12-31$214.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001411690-25-000037.Report this figure158Total assets, Q1 FY2024, at 2024-03-31$158.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001411690-24-000021.Report this figure129Total assets, Q2 FY2024, at 2024-06-30$129.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001411690-24-000049.Report this figure87.4Total assets, Q3 FY2024, at 2024-09-30$87.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure76.7Total assets, FY2024, at 2024-12-31$76.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001411690-26-000007.Report this figure78.4Total assets, Q1 FY2025, at 2025-03-31$78.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure76.0Total assets, Q2 FY2025, at 2025-06-30$76.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure79.1Total assets, Q3 FY2025, at 2025-09-30$79.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure73.6Total assets, FY2025, at 2025-12-31$73.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure64.8Total assets, Q1 FY2026, at 2026-03-31$64.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure47.6Total assets, Q2 FY2026, at 2026-06-30$47.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Current liabilities$m40.2Current liabilities, Q3 FY2023, at 2023-09-30$40.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001411690-23-000082.Report this figure100Current liabilities, FY2023, at 2023-12-31$100.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001411690-25-000037.Report this figure58.5Current liabilities, Q1 FY2024, at 2024-03-31$58.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001411690-24-000021.Report this figure37.2Current liabilities, Q2 FY2024, at 2024-06-30$37.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001411690-24-000049.Report this figure33.0Current liabilities, Q3 FY2024, at 2024-09-30$33.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure37.3Current liabilities, FY2024, at 2024-12-31$37.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001411690-26-000007.Report this figure26.4Current liabilities, Q1 FY2025, at 2025-03-31$26.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure24.2Current liabilities, Q2 FY2025, at 2025-06-30$24.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure23.0Current liabilities, Q3 FY2025, at 2025-09-30$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure22.9Current liabilities, FY2025, at 2025-12-31$22.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure21.2Current liabilities, Q1 FY2026, at 2026-03-31$21.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure10.0Current liabilities, Q2 FY2026, at 2026-06-30$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Total liabilities$m62.9Total liabilities, Q3 FY2023, at 2023-09-30$62.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001411690-23-000082.Report this figure118Total liabilities, FY2023, at 2023-12-31$118.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001411690-25-000037.Report this figure75.2Total liabilities, Q1 FY2024, at 2024-03-31$75.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001411690-24-000021.Report this figure49.0Total liabilities, Q2 FY2024, at 2024-06-30$49.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001411690-24-000049.Report this figure38.5Total liabilities, Q3 FY2024, at 2024-09-30$38.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure41.3Total liabilities, FY2024, at 2024-12-31$41.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001411690-26-000007.Report this figure30.2Total liabilities, Q1 FY2025, at 2025-03-31$30.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure30.6Total liabilities, Q2 FY2025, at 2025-06-30$30.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure29.3Total liabilities, Q3 FY2025, at 2025-09-30$29.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure29.2Total liabilities, FY2025, at 2025-12-31$29.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure27.3Total liabilities, Q1 FY2026, at 2026-03-31$27.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure16.0Total liabilities, Q2 FY2026, at 2026-06-30$16.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m119Shareholders' equity, Q3 FY2023, at 2023-09-30$119.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure96.2Shareholders' equity, FY2023, at 2023-12-31$96.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001411690-26-000007.Report this figure82.8Shareholders' equity, Q1 FY2024, at 2024-03-31$82.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure80.3Shareholders' equity, Q2 FY2024, at 2024-06-30$80.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure48.9Shareholders' equity, Q3 FY2024, at 2024-09-30$48.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure35.4Shareholders' equity, FY2024, at 2024-12-31$35.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure48.2Shareholders' equity, Q1 FY2025, at 2025-03-31$48.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure45.4Shareholders' equity, Q2 FY2025, at 2025-06-30$45.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure49.8Shareholders' equity, Q3 FY2025, at 2025-09-30$49.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure44.4Shareholders' equity, FY2025, at 2025-12-31$44.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure37.5Shareholders' equity, Q1 FY2026, at 2026-03-31$37.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure31.6Shareholders' equity, Q2 FY2026, at 2026-06-30$31.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure

Cash flow

Operating cash flow−$4.7m, Q2 FY2026
Bionano Genomics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(26.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$26.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001411690-24-000063. Derived: 9-month figure less the 6-month figure.Report this figure(29.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$29.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001411690-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure(28.1)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$28.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure(21.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$21.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001411690-25-000083. Derived: 6-month figure less the 3-month figure.Report this figure(13.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001411690-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure(6.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(2.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(3.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001411690-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure(5.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001411690-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure(4.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001411690-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(5.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure(4.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001411690-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)11.55m, Q2 FY2026
Bionano Genomics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares29.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3028,970,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001411690-23-000082.Report this figure30.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3130,205,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001411690-24-000021.Report this figure31.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3031,498,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001411690-24-000049.Report this figure35.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3035,001,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001411690-24-000063.Report this figure0.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31879,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001411690-25-000046.Report this figure1.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,126,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001411690-25-000083.Report this figure1.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,431,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure2.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-312,694,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure3.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-303,441,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure5.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-305,338,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001411690-25-000093.Report this figure11.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3110,979,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001411690-26-000028.Report this figure11.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3011,546,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure

Shares outstanding: 11.78mShares outstanding, period not labelled, at 2026-08-0611,777,000 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001411690-26-000044.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.